Healtheuniverse Inc. (PINKSHEETS: HLUN), a diversified biotechnology development firm specializing in the development and commercialization of patented biopharmaceutical and biomedical products is pleased to report that progress is being made towards the acquisition of new expanded lab facilities in preparation for a major pre-clinical trial utilizing its proprietary non-embryonic stem cell technology. The Company's efforts also continue to be focused on opportunities and collaborative efforts with the Economic Development Board of Singapore. These domestic and international efforts support the Company's pursuit of advanced scientific protocols in preparation for the first human clinical trials using the company's proprietary stem cell technology.
